Dr. Borad’s research focuses on exploring various molecular and immunological subtypes and discovering novel targeted therapies for providing precision medicine for hepatobiliary and pancreatic cancer patients. He is Associate Professor Medicine, College of Medicine, Consultant, Medical Oncology; Program Leader, Gene and Virus Therapy Program for the Mayo Clinic Cancer Center; Co-Director, Precision Cancer Therapeutics Program, Mayo Clinic Center for Individualized Medicine, Mayo Clinic, Phoenix, Arizona. He also serves on the NIH Drug Discovery and Pharmacology (DMP) Study Section as a Standing Member, NIH Hepatobiliary Cancer Task Force and Vice Chair of the International Cholangiocarcinoma Research Network (ICRN).